January 4, 2022

Geneseeq’s cancer early detection study series DECIPHER yield another publication in HEPATOLOGY to explore the performance of cfDNA fragmentomics in liver cancer

0 Comments3 Minutes

November 22, 2021

Geneseeq announces new publication utilizing ultradeep sequencing technology Automated TTriple Groom sequencing (ATG-seq) to monitor minimal residual disease in postoperative non-small cell lung cancer

0 Comments3 Minutes

November 11, 2021

Geneseeq Forms Lung Cancer Strategic Partnerships with Takeda and AstraZeneca on the Same Day

0 Comments1 Minutes

November 8, 2021

Geneseeq collaborates on research identifying predictive biomarkers for guiding personalized adjuvant treatment in resected EGFR-positive non-small cell lung cancer

0 Comments4 Minutes

October 27, 2021

Geneseeq Study Shows High Performance Results in Colorectal Cancer Early Detection

0 Comments4 Minutes

October 13, 2021

Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D

0 Comments2 Minutes

September 15, 2021

Geneseeq Presents 10 studies on MRD, early cancer detection, cancer diagnosis and cancer biology research at EMSO 2021

0 Comments8 Minutes

September 8, 2021

Geneseeq Presents ctDNA Early Lung Cancer Detection Data at WCLC

0 Comments2 Minutes

August 31, 2021

Geneseeq Study Evaluates ctDNA MRD to Predict Response to Therapy and Assess Prognosis in Locally Advanced Rectal Cancer

0 Comments3 Minutes

June 24, 2021

Geneseeq works with HUTCHMED and AstraZeneca in MET inhibitor approval for lung cancer patients in China

0 Comments2 Minutes